- Home
- MTEX vs IBO Comparison
MTEX vs IBO Comparison
Compare MTEX & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- IBO
- Stock Information
- Founded
- MTEX 1993
- IBO 2018
- Country
- MTEX United States
- IBO United States
- Employees
- MTEX N/A
- IBO N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- IBO
- Sector
- MTEX Health Care
- IBO
- Exchange
- MTEX Nasdaq
- IBO NYSE
- Market Cap
- MTEX 19.9M
- IBO 5.1M
- IPO Year
- MTEX 1999
- IBO 2024
- Fundamental
- Price
- MTEX $10.00
- IBO $0.50
- Analyst Decision
- MTEX
- IBO
- Analyst Count
- MTEX 0
- IBO 0
- Target Price
- MTEX N/A
- IBO N/A
- AVG Volume (30 Days)
- MTEX 1.7K
- IBO 10.7M
- Earning Date
- MTEX 05-20-2025
- IBO 05-23-2025
- Dividend Yield
- MTEX N/A
- IBO N/A
- EPS Growth
- MTEX N/A
- IBO N/A
- EPS
- MTEX 1.32
- IBO N/A
- Revenue
- MTEX $117,866,000.00
- IBO N/A
- Revenue This Year
- MTEX N/A
- IBO N/A
- Revenue Next Year
- MTEX N/A
- IBO N/A
- P/E Ratio
- MTEX $7.58
- IBO N/A
- Revenue Growth
- MTEX N/A
- IBO N/A
- 52 Week Low
- MTEX $6.75
- IBO $0.37
- 52 Week High
- MTEX $16.49
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- MTEX 49.29
- IBO N/A
- Support Level
- MTEX $9.70
- IBO N/A
- Resistance Level
- MTEX $11.90
- IBO N/A
- Average True Range (ATR)
- MTEX 0.26
- IBO 0.00
- MACD
- MTEX -0.03
- IBO 0.00
- Stochastic Oscillator
- MTEX 24.00
- IBO 0.00
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.